StockNews.com Initiates Coverage on NantHealth (NASDAQ:NH)

Research analysts at StockNews.com initiated coverage on shares of NantHealth (NASDAQ:NHGet Free Report) in a note issued to investors on Tuesday. The firm set a “hold” rating on the stock.

NantHealth Stock Performance

Shares of NantHealth stock opened at $0.34 on Tuesday. NantHealth has a 12-month low of $1.24 and a 12-month high of $9.75. The firm has a market capitalization of $2.63 million, a price-to-earnings ratio of -0.04 and a beta of 1.82. The firm’s 50 day simple moving average is $0.39 and its two-hundred day simple moving average is $0.39.

Hedge Funds Weigh In On NantHealth

Hedge funds and other institutional investors have recently modified their holdings of the business. Atria Wealth Solutions Inc. increased its position in shares of NantHealth by 117.7% during the second quarter. Atria Wealth Solutions Inc. now owns 491,942 shares of the company’s stock valued at $205,000 after acquiring an additional 265,949 shares during the last quarter. Millennium Management LLC acquired a new stake in shares of NantHealth during the second quarter valued at about $110,000. Goldman Sachs Group Inc. acquired a new stake in shares of NantHealth during the second quarter valued at about $36,000. Finally, Susquehanna International Group LLP acquired a new stake in shares of NantHealth during the first quarter valued at about $25,000. 4.50% of the stock is owned by hedge funds and other institutional investors.

NantHealth Company Profile

(Get Free Report)

NantHealth, Inc engages in the provision of enterprise solutions that help businesses transform complex data into actionable insights. It is also involved in marketing solutions as a comprehensive integrated solution that includes clinical decision support, payer engagement solutions, data analysis, and network monitoring and management.

Featured Stories

Receive News & Ratings for NantHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NantHealth and related companies with MarketBeat.com's FREE daily email newsletter.